iQ-solutions

by Sydney Neuroimaging Analysis Centre Pty  · Based in Australia →Providing novel insights into neurological diseases through Artificial Intelligence.
Neurology Radiology

Contact for details
Regulatory Status Disclosed

Overview

iQ-solutions™ is a standalone software medical device developed by Sydney Neuroimaging Analysis Centre (SNAC) that leverages artificial intelligence (AI) algorithms, based on deep neural network technology, to analyze brain MRI scans in Digital Imaging and Communications in Medicine (DICOM) format. The tool performs both cross-sectional and longitudinal segmentation, providing precise measurements of segmented brain structures. It generates quantitative reports and annotation masks in DICOM format, designed to integrate seamlessly with existing Picture Archiving and Communication Systems (PACS) as a ‘zero-click’ solution, minimizing disruption to clinical workflows.

Intended for use by relevant healthcare professionals, iQ-solutions™ assists in monitoring structural changes in brain parenchyma associated with various neurological disorders, including Multiple Sclerosis (MS) and cognitive disorders. It helps reflect disease status, track progression over time, and evaluate therapeutic responses. By automating and improving the quantification of brain structures that would otherwise require impractical manual measurements, iQ-solutions™ aims to enhance traditional radiology practices, reduce radiologist workload, and improve overall efficiency and precision in neuroimaging analysis.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-based deep neural network algorithms for MRI analysis
  • Cross-sectional and longitudinal brain MRI analysis
  • Automatic segmentation and quantification of brain structures
  • Disease-specific reports (e.g., iQ-MS, iQ-COG)
  • Seamless integration with PACS systems ('zero-click solution')
  • Accurate and reproducible quantitative measurements
  • Real-time, efficient reporting
  • Visualization of relevant segmentations
  • Detection of new or enlarging lesions
  • Measurement of brain volume changes and pathology

Use Cases

  • Monitoring Multiple Sclerosis (MS) progression and treatment response
  • Assessing cognitive disorders and dementia
  • Quantitative MRI brain analysis in clinical practice
  • Enhancing radiology reporting efficiency and precision
  • Supporting clinical trials for neurological diseases
  • Early detection and management of disease progression in chronic neurological conditions

What Physicians Need to Know

Brain MRI/CT Analysis
iQ-solutions specializes in quantitative MRI brain analysis, offering accurate and reproducible quantification and visualization of brain structures from MRI scans, thereby eliminating the need for manual measurements [2]. It features AI-driven modules, iQ-MS for multiple sclerosis and iQ-COG for cognitive disorders, which provide automated, objective measures for neuroimaging workflows [1]. The platform processes brain MRI scans in DICOM format using deep neural network technology, trained on over 8,500 expertly annotated brain scans [3, 4]. It generates real-time quantitative metrics in customizable disease-specific reports and supports both cross-sectional and longitudinal analysis pipelines to monitor structural changes over time [2, 5].
Neurodegenerative Disease Screening
The iQ-MS and iQ-COG modules are designed to assist with the early detection of disease progression and facilitate more informed reporting for patients with chronic neurological conditions such as multiple sclerosis and cognitive disorders [1]. A validation study showed that iQ-MS achieved a higher sensitivity (93.3%) in detecting lesion activity in MS compared to standard radiology reports (58.3%), and its performance in measuring lesion activity and brain volume loss matched that of a core clinical trial imaging lab [4]. This capability is crucial for enhancing the precision of neurodegenerative disease management [4].
Physician Tip

Leverage iQ-solutions for objective, quantitative assessment of brain MRI scans, particularly for monitoring neurodegenerative conditions like MS and cognitive disorders. The automated reports can enhance diagnostic confidence and track disease progression more precisely than visual inspection alone. Integrate the longitudinal analysis pipeline to observe subtle brain volume changes and lesion activity over time, aiding in treatment efficacy evaluation and patient management. The high sensitivity in detecting lesion activity can support earlier intervention strategies.

iQ-solutions is designed as a 'zero-click' solution that seamlessly integrates with existing clinical workflows, facilitating secure communication between the Picture Archiving and Communication System (PACS) and its analysis pipeline without disrupting operations or exposing private health information outside the network [2, 5]. The AI tool returns visualizations of relevant segmentations to the PACS for radiologist review [3]. This integration capability ensures that advanced AI-powered quantitative MRI analytics are readily accessible within everyday radiology services.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Contact for details Not available publicly
DeploymentOn-premise (PACS integrated)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

iQ-solutions™ received FDA 510(k) clearance (K231929) on December 18, 2023, as a Class II medical device under regulation 21 CFR 892.2050 (Medical image management and processing system), with product codes QIH and LLZ. It is intended for automatic annotation, visualization, and quantification of segmentable brain structures from brain MRI scans.

Integrations
EHR Not specified
Specialties Neurology, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate iQ-solutions

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

British Journal of Radiology | Oxford Academic
Artificial intelligence in neuroradiology: a review of Food and Drug Administration-regulated algorithms
iQ-solutions (Sydney Neuroimaging Analysis Centre, Sydney, Australia) and Icobrain are FDA-cleared AI algorithms for monitoring longitudinal MS lesion volumes and whole brain volume change. In an analysis of 387 clinical MS MRI scans, iQ-solutions demonstrated a sensitivity of 93.3% for new lesion detection, compared to 58.3% from standard radiology reports, using the expert consensus as reference standard.
2026-05
SNAC
SNAC'S AI-BASED SOLUTION FOR MONITORING MULTIPLE SCLEROSIS VALIDATED IN REAL-WORLD MRI COHORT
Published in Nature Portfolio's npj Digital Medicine, SNAC's clinically integrated AI-based tool, iQ-SolutionsTM, outperformed standard radiology reports for detection of disease activity in a multicentre, real-world multiple sclerosis (MS) cohort.
2023-10
SNAC
SNAC and I-MED Radiology Network expand quantitative neuroimaging capability with enterprise deployment of iQ-solutions
Sydney Neuroimaging Analysis Centre (SNAC) announced the enterprise deployment of the iQ-solutionsu2122 platform across the I-MED Radiology network, enhancing access to quantitative brain MRI analysis for clinicians and patients across Australia.
2026-05
SNAC
SNAC and Qscan Group Complete Enterprise Deployment of iQ-Solutions
Sydney Neuroimaging Analysis Centre (SNAC) successfully deployed iQ-Solutions, its AI platform for quantitative brain MRI analysis, across the Qscan Group network, integrating iQ-MS and iQ-COG into neuroimaging workflows.
2025-12
GPI Group
GPI Group and IQ-Solutions Enter into Strategic Partnership
GPI Group announced a strategic partnership with IQ-Solutions, a systems integrator in Kazakhstan, to develop joint projects in sustainable development, digitalization, and ESG initiatives, as well as implement advanced IT and OT technologies.
2025-11
Hitachi Vantara
Hitachi Vantara Announces General Availability of Hitachi iQ and New AI Discovery Service to Help Businesses Become AI-Ready
Hitachi Vantara announced the general availability of its Hitachi iQ portfolio of AI-ready infrastructure, solutions, and services, including NVIDIA DGX BasePODu2122 certification, to help businesses become AI-ready.
2024-07
Luther Rechtsanwaltsgesellschaft
Focus on digital consulting expertise: Luther advises Sycor on the sale of subsidiary IQ Solutions
IT consulting company Sycor sold its Munich-based subsidiary Sycor IQ Solutions, a license specialist, to the newly founded Cohemi Group from Frankfurt.
2024-06
GovCon Media Mosiac
IQ SOLUTIONS, INC. u2014 Federal Contract Award
IQ Solutions, Inc. was awarded a $2.4 million federal contract by the Department of Health and Human Services on July 14, 2026.
2026-07

Videos

Product demos, reviews, and walkthroughs for iQ-solutions.

View all on YouTube

Frequently Asked Questions

iQ-solutions is designed to integrate with existing EHR platforms, aiming to augment clinical decision-making and streamline workflows without replacing physician judgment. Seamless integration through secure APIs helps minimize disruption and ensures insights are accessible within familiar interfaces.
iQ-solutions prioritizes patient data privacy and security, employing robust encryption, de-identification protocols, and strict access controls to ensure full compliance with HIPAA and other relevant healthcare regulations. Organizations must also implement internal quality management systems and audit logs for high-risk AI systems.
iQ-solutions serves as a decision support tool, not a substitute for a physician's clinical judgment, and may not account for every unique patient variable or rare condition. Physicians must be aware of potential biases in the training data, the need for local validation, and the importance of critically evaluating AI-generated insights.
Alternatives to iQ-solutions include other specialized AI diagnostic or decision support tools, as well as traditional manual data analysis and expert consultations. iQ-solutions aims to differentiate itself through its specific focus, integration capabilities, and the actionable, real-time insights it provides to enhance clinical efficiency.
The pricing for iQ-solutions typically involves tiered subscription models, with costs influenced by factors such as data acquisition and preparation, integration with existing systems, regulatory compliance, and ongoing monitoring. The total cost extends beyond licensing to include infrastructure, staff training, and continuous maintenance.
iQ-solutions is developed using validated clinical datasets and undergoes rigorous testing to ensure accuracy and reliability, with performance often monitored over time. However, local validation within specific clinical contexts is crucial, as is understanding that AI models can perpetuate biases present in their training data.
iQ-solutions typically offers comprehensive training programs for physicians and staff to ensure effective utilization and interpretation of AI-generated insights. Ongoing technical support and educational resources are provided to help users stay updated and address any operational challenges.

Related Tools

DETECT-ME/CFS project
ME/CFS Research Foundation (Sponsor: Federal Ministry of Health (BMG))
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Neurotrack
Neurotrack
Clinical Decision Support & Reference
Neurotrack is a cognitive care enablement platform that provides clinically validated, FDA class II device assessments and care planning support to identify and manage cognitive decline and dementia earlier and with greater accuracy.
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Onera SleepMap
Onera B.V.
Neurology AI
Onera SleepMap is an AI-powered sleep analysis software that processes polysomnography data, part of Onera Health's innovative patch-based system for at-home and in-lab sleep studies. The system aims to make clinical-grade sleep diagnostics more accessible and user-friendly, providing comprehensive data comparable to traditional in-lab PSG.
JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

See all Neurology AI tools →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.